Compounds of formula (I), and pharmaceutically acceptable salts and esters thereof: (I); wherein Q, R2, X, Y and Z are as defined herein; are inhibitors of the hepatitis C virus (HCV) NS3 protease ##STR00001##

 
Web www.patentalert.com

< 3terminal sequence of hepatitis C virus genome and diagnostic and therapeutic uses thereof

< Ribonuclease resistant RNA preparation and utilization

> Sequences of hepatitis C virus genotypes and their use as prophylactic, therapeutic and diagnostic agents

> Highly sensitive gene detection and localization using in situ branched-DNA hybridization

~ 00293